• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病和早期糖代谢异常患者非靶冠状动脉病变的现状及机制洞察

Current status and mechanistic insights into nontarget coronary lesions in patients with diabetes and early abnormal glucose metabolism.

作者信息

Liu Shi-Qi, Wang Dong, Tang Cheng-Chun

机构信息

School of Medicine, Southeast University, Nanjing 210009, Jiangsu Province, China.

Department of Cardiology, Zhongda Hospital, Southeast University, Nanjing 210009, Jiangsu Province, China.

出版信息

World J Diabetes. 2025 Sep 15;16(9):107693. doi: 10.4239/wjd.v16.i9.107693.

DOI:10.4239/wjd.v16.i9.107693
PMID:40980306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12444280/
Abstract

The introduction of drug-eluting stents has significantly reduced the incidence of in-stent restenosis. Despite this, recurrent cardiovascular events related to untreated nontarget lesions (NTLs) are becoming more common and accounting for more than 50% of all recurrent cardiovascular events. In patients with diabetes, factors such as prolonged disease duration, poor glycemic control, insulin use, and inadequate lipid management may exacerbate the progression of NTLs and adverse cardiovascular events. Additionally, glycemic fluctuations have been linked to an increased risk of future cardiovascular events in patients with early glucose metabolism abnormalities and acute hyperglycemia. In this review, we explored the clinical and plaque characteristics of patients with diabetes and early glucose metabolism disorders, the percutaneous coronary intervention strategies for NTLs, and their prognostic implications. Furthermore, we investigated the mechanistic links between adverse cardiovascular outcomes and elevated inflammation, oxidative stress, hypercoagulability, and endothelial dysfunction.

摘要

药物洗脱支架的引入显著降低了支架内再狭窄的发生率。尽管如此,与未治疗的非靶病变(NTLs)相关的复发性心血管事件正变得越来越普遍,占所有复发性心血管事件的50%以上。在糖尿病患者中,病程延长、血糖控制不佳、使用胰岛素和脂质管理不足等因素可能会加剧NTLs的进展和不良心血管事件。此外,血糖波动与早期糖代谢异常和急性高血糖患者未来心血管事件风险增加有关。在本综述中,我们探讨了糖尿病和早期糖代谢紊乱患者的临床和斑块特征、NTLs的经皮冠状动脉介入治疗策略及其预后意义。此外,我们还研究了不良心血管结局与炎症、氧化应激、高凝状态和内皮功能障碍之间的机制联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd32/12444280/1c0bea6b0b6e/wjd-16-9-107693-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd32/12444280/1c0bea6b0b6e/wjd-16-9-107693-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd32/12444280/1c0bea6b0b6e/wjd-16-9-107693-g001.jpg

相似文献

1
Current status and mechanistic insights into nontarget coronary lesions in patients with diabetes and early abnormal glucose metabolism.糖尿病和早期糖代谢异常患者非靶冠状动脉病变的现状及机制洞察
World J Diabetes. 2025 Sep 15;16(9):107693. doi: 10.4239/wjd.v16.i9.107693.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.孕前糖尿病与妊娠:内分泌学会和欧洲内分泌学会联合临床实践指南
Eur J Endocrinol. 2025 Jun 30;193(1):G1-G48. doi: 10.1093/ejendo/lvaf116.
4
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.糖尿病合并妊娠:内分泌学会与欧洲内分泌学会联合临床实践指南
J Clin Endocrinol Metab. 2025 Jul 13. doi: 10.1210/clinem/dgaf288.
5
Systemic Inflammatory Response Syndrome全身炎症反应综合征
6
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
7
Drug-eluting stents versus bare-metal stents for acute coronary syndrome.药物洗脱支架与裸金属支架治疗急性冠状动脉综合征的比较
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD012481. doi: 10.1002/14651858.CD012481.pub2.
8
Glycaemic control in labour with diabetes: GILD, a scoping study.糖尿病产妇分娩期间的血糖控制:GILD,一项范围界定研究。
Health Technol Assess. 2025 Aug;29(41):1-150. doi: 10.3310/KHGD2761.
9
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.用于管理1型糖尿病患者血糖水平的混合闭环系统:系统评价与经济建模
Health Technol Assess. 2024 Dec;28(80):1-190. doi: 10.3310/JYPL3536.
10
Linking Estimated Glucose Disposal Rate to Major Adverse Cardio-Cerebrovascular Events in Populations With and Without Diabetes: A Systematic Review and Meta-Analysis.将估计的葡萄糖处置率与有糖尿病和无糖尿病人群的主要心血管不良事件相联系:一项系统评价和荟萃分析
Clin Med Insights Endocrinol Diabetes. 2025 Sep 15;18:11795514251372702. doi: 10.1177/11795514251372702. eCollection 2025.

本文引用的文献

1
The progression of non-culprit coronary lesion is related to higher SII, SIRI, and PIV in patients with ACS.在急性冠状动脉综合征(ACS)患者中,非罪犯冠状动脉病变的进展与较高的全身炎症反应指数(SII)、全身免疫炎症指数(SIRI)和血小板炎症反应指数(PIV)相关。
Medicine (Baltimore). 2024 Dec 27;103(52):e41094. doi: 10.1097/MD.0000000000041094.
2
The future of complete revascularisation: prioritising imaging-guided non-culprit lesion assessment.完全血运重建的未来:优先进行影像引导下的非罪犯病变评估。
EuroIntervention. 2025 Feb 17;21(4):e198-e199. doi: 10.4244/EIJ-E-25-00002.
3
Functional or anatomical assessment of non-culprit lesions in acute myocardial infarction.
急性心肌梗死中非罪犯病变的功能或解剖学评估。
EuroIntervention. 2025 Feb 17;21(4):e217-e228. doi: 10.4244/EIJ-D-24-00720.
4
Relationship between stress hyperglycemia ratio and progression of non target coronary lesions: a retrospective cohort study.应激性高血糖比值与非靶冠状动脉病变进展的关系:一项回顾性队列研究。
Diabetol Metab Syndr. 2025 Jan 22;17(1):27. doi: 10.1186/s13098-024-01575-7.
5
Comparing FFR-Guided Complete Revascularization and Conservative Management for Non-Culprit Lesions in STEMI Patients With Multivessel Disease: A Systematic Review and Meta-Analysis.比较FFR指导的完全血运重建与保守治疗对多支血管病变STEMI患者非罪犯病变的疗效:一项系统评价和荟萃分析
Catheter Cardiovasc Interv. 2025 Feb;105(3):633-642. doi: 10.1002/ccd.31379. Epub 2024 Dec 24.
6
Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe): a multicentre, randomised, non-inferiority trial.定量血流比与分数血流储备用于冠状动脉血运重建指导(FAVOR III Europe):一项多中心、随机、非劣效性试验。
Lancet. 2024 Nov 9;404(10465):1835-1846. doi: 10.1016/S0140-6736(24)02175-5. Epub 2024 Oct 30.
7
Immediate versus staged complete revascularisation in patients presenting with STEMI and multivessel disease.ST段抬高型心肌梗死合并多支血管病变患者的即刻与分期完全血运重建。
EuroIntervention. 2024 Jul 15;20(14):e865-e875. doi: 10.4244/EIJ-D-23-00882.
8
Vulnerable plaque features and adverse events in patients with diabetes mellitus: a post hoc analysis of the COMBINE OCT-FFR trial.糖尿病患者易损斑块特征和不良事件:COMBINE OCT-FFR 试验的事后分析。
EuroIntervention. 2024 Jun 3;20(11):e707-e717. doi: 10.4244/EIJ-D-23-00628.
9
Association between diabetes mellitus and primary restenosis following endovascular treatment: a comprehensive meta-analysis of randomized controlled trials.糖尿病与血管内治疗后原发性再狭窄之间的关联:随机对照试验的综合荟萃分析。
Cardiovasc Diabetol. 2024 Apr 22;23(1):132. doi: 10.1186/s12933-024-02201-6.
10
FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction.FFR 引导的心肌梗死患者完全血运重建或罪犯病变血运重建。
N Engl J Med. 2024 Apr 25;390(16):1481-1492. doi: 10.1056/NEJMoa2314149. Epub 2024 Apr 8.